drugset

drugset / Trial / NCT01089855

Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy Pain

NCT01089855 ↗

Phase 4 Completed 123 enrolled Novartis

NaSingle-groupOpen-labelTreatment

Summary

The trial is designed to evaluate the efficacy and tolerability of carbamazepine in neuropathic pain in diabetic patients

Timeline

Start: 2009-12
Primary completion: 2010-07
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Carbamazepine	Small molecule	—	—

Indications